Avalanche Biotechnologies CEO Laurent Fischer's 2021 pay falls 58% to $9M
Avalanche Biotechnologies reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
Avalanche Biotechnologies reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, ten executives at Avalanche Biotechnologies received on average a compensation package of $2.7M, a 63% decrease compared to previous year.
Average pay of disclosed executives at Avalanche Biotechnologies
Laurent Fischer, Chief Executive Officer, received $9M in total, which decreased by 58% compared to 2020. 84% of Fischer's compensation, or $7.5M, was in option awards. Fischer also received $298K in non-equity incentive plan, $621K in salary, $562K in stock awards, as well as $2K in other compensation.
For fiscal year 2021, the median employee pay was $188,229 at Avalanche Biotechnologies. Therefore, the ratio of Laurent Fischer's pay to the median employee pay was 48 to one.
Christopher DeRespino, Chief Financial Officer, received a compensation package of $4.3M. 93% of the compensation package, or $4M, was in option awards.
Angela Thedinga, Chief Technology Officer, earned $3.2M in 2021, a 47% increase compared to previous year.
Leone Patterson, Chief Financial Officer, received $2.9M in 2021, which decreases by 33% compared to 2020.
Kishor Peter Soparkar, Chief Operating Officer, earned $2.5M in 2021.
Julie Clark, Chief Medical Officer, received $2.4M in 2021.
Brigit Riley, Chief Scientific Officer, earned $2M in 2021.
Rupert D'Souza, Chief Financial Officer, received $557K in 2021.
Thomas Leung, Chief Financial Officer, earned $501K in 2021, a 74% decrease compared to previous year.
Jack Thrift, Chief Financial Officer, received $65K in 2021.
Related executives
Laurent Fischer
Avalanche Biotechnologies
Chief Executive Officer
Rupert D'Souza
Avalanche Biotechnologies
Chief Financial Officer
Leone Patterson
Avalanche Biotechnologies
Chief Financial Officer
Christopher DeRespino
Avalanche Biotechnologies
Chief Financial Officer
Jack Thrift
Avalanche Biotechnologies
Chief Financial Officer
Thomas Leung
Avalanche Biotechnologies
Chief Financial Officer
Kishor Soparkar
Avalanche Biotechnologies
Chief Operating Officer
Brigit Riley
Avalanche Biotechnologies
Chief Scientific Officer
You may also like
Source: SEC filing on April 26, 2022.